BD Institute for Medication Management Excellence blog

1 2 3

Drug diversion: Getting to root cause

di Jun 10, 2019

Challenged with investigating suspected diversion cases early in her career, BD thought leader Doina Dumitru developed a unique perspective on how to prevent these tragic events from happening in the first place. Learn why we need to get to root cause to address diversion.

A call to action on hospital drug diversion

di Jun 4, 2019

Because hospital drug diversion has been understudied, the BD Institute for Medication Management Excellence commissioned a new national survey of more than 650 hospital executives and providers to better understand diversion perceptions, behaviors and solutions.

Immunizations at risk: Understanding disruptions in the cold chain

ms May 20, 2019

Vaccine-related supply chain and logistics are crucial to effective immunization programs. While their significance is often overlooked, disruptions within the cold chain can put patients at risk.

Inspiring excellence: Winners of the 2019 ANA Innovation Awards

cl May 6, 2019

Winners of the first inaugural ANA Innovation Awards have been announced. Learn about the individual nurse and nurse-led team winners and their inspiring new ideas.

Cybersecurity and patient safety: Developing a culture of transparency among healthcare industry stakeholders

io Apr 29, 2019

A fast-growing group of healthcare industry associations are working with the US government to promote information-sharing in cybersecurity and address the unique risks that come with patient interaction. Read about the newly-formed Healthcare and Public Health Sector Coordinating Council (HSCC) and the task-force that developed a Joint Security Plan to help medical device companies achieve transparency.

Where’s my med? The challenges of patient-specific medication management

ms Apr 22, 2019

Tracking down patient-specific meds can be a significant challenge for nursing and pharmacy alike. BD thought leaders from both departments explore simple and intuitive solutions that may help to improve the problem.

Diversion in U.S. hospitals: A pharmacist's perspective on the issues and challenges

di Apr 8, 2019

David Swenson, RPh, Vice President of Medical Affairs at BD, reflects on conversations with customers to provide some perspective on an underreported aspect of the opioid crisis – healthcare professional drug diversion - which is of growing importance to hospitals across the United States.

Burden of drug shortages on clinical care

ms Mar 25, 2019

The impact of drug shortages continues to take a clinical and economic toll on patients and healthcare systems.

Connectivity and the impact on patient care

ms Mar 11, 2019

Perry Flowers, RPh, MS, VP Medical Affairs, Enterprise Medication Management at BD, discusses the need for connected solution models when a single-platform is not enough.

From cutting-edge to legacy devices: maintaining product security in the hospital

io Feb 25, 2019

David Scott, Director of Technical Consulting at BD, weighs in on key barriers to medical device security, the FDA’s changing guidelines and “unpatchable” medical devices.

1 2 3

This site uses cookies. If you click accept cookies then all cookies will be written. Please review our cookies policy and configure your cookies for your experience.